Replies to post #79417 on Ariad Pharmaceuticals Inc fka ARIA

[jbog]

vidpok,

Ceritinib was approved in 2014 as a 2nd line after Criz just like the Alta trial patients. Brigs results are close to double those of Ceritinib.


Novartis in the 1st line trial went head to head against Chemo which hasn't been sed in years.

Todays standard 1st line tretment is Criz and that's what it should be tested against.